The Indian Society for Clinical Research (ISCR), an association of clinical research professionals, has announced the appointment of Dr Seema Pai as its President for the term 2025-2028.
Dr Seema takes over from Dr Sanish Davis, who served as President from 2021 to 2025. Alongside Dr Seema, Anirban Roychowdhury has been appointed as General Secretary, and Amita Bhave as Treasurer for the new term.
Commenting on her focus at a time when clinical research in India is undergoing significant transformation with advancements in technology and evolving regulatory frameworks, Dr Seema Pai said, “As ISCR celebrates its 20th anniversary in 2025, I am honoured to lead ISCR at this pivotal moment. India has made remarkable strides in clinical research, from late-phase trials in the early 2000s to pioneering innovations like indigenous CAR-T cell therapy currently in 2025. Our focus on quality, speed, and ethics has earned global trust, leading to transformative work and advancements in clinical trials."
Dr Seema Pai has over 20 years of experience in clinical research and currently leads the Global Site & Study Operations for the India Cluster (India, South Africa & Sub-Saharan Africa) at Pfizer.
Before Pfizer, Dr Seema was heading the development division of Daiichi Sankyo India Pharma where she was responsible for India Strategy, Clinical Development, Clinical Operations, collaboration with key acquisitions in India for synergies.
